Susan Tobey Denman, MD | |
18345 Sw Alexander St, Suite B, Aloha, OR 97006-3960 | |
(503) 649-9477 | |
(503) 649-1272 |
Full Name | Susan Tobey Denman |
---|---|
Gender | Female |
Speciality | Dermatology |
Location | 18345 Sw Alexander St, Aloha, Oregon |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1700871803 | NPI | - | NPPES |
38D0621698 | Other | CLIA | |
070002027 | Other | RAILROAD MEDICARE | |
048142000 | Other | REGENCE BLUE CROSS BLUE SHIELD OF OREGON | |
260760 | Medicaid | OR |
Mailing Address | Practice Location Address |
---|---|
Susan Tobey Denman, MD 4546 Sw Humphrey Blvd, Portland, OR 97221-2305 Ph: () - | Susan Tobey Denman, MD 18345 Sw Alexander St, Suite B, Aloha, OR 97006-3960 Ph: (503) 649-9477 |
News Archive
Prostate cancer patients who receive intensity modulated radiation therapy (IMRT) are less apt to suffer serious gastrointestinal complications following their treatment than those who receive three-dimensional conformal radiotherapy (CRT), according to new research from the University of Pennsylvania School of Medicine.
Today, everyone carries a toxic load of industrially-produced chemicals in their bloodstream: pesticides, plasticizers, disinfectant products, flame-retardants, surfactants, and UV filters. These chemicals are harmful to everyone, but they are particularly dangerous to pregnant women and their developing fetuses.
As part of the company's commitment to chronic obstructive pulmonary disease patients, Boehringer Ingelheim Pharmaceuticals, Inc., a leader in respiratory health, is updating healthcare professionals and patients that the transition to COMBIVENT RESPIMAT (ipratropium bromide and albuterol) Inhalation Spray for the maintenance treatment of COPD is nearly complete.
With most liver cancer caused by undetected or untreated hepatitis B or C viral infection, the 22,000 new cases of liver cancer that are diagnosed each year could be dramatically reduced if Congress took decisive action to close the funding gap for federal viral hepatitis education, screening, and surveillance programs, the National Viral Hepatitis Roundtable (NVHR) said today.
› Verified 5 days ago